P2RX7 and osteoporosis: Therefore, in the present study, we genotyped 15 non-synonymous P2RX7 polymorphisms in a cohort of fracture patients in the southeastern part of the Netherlands, and tested whether genetic variation in this purinergic receptor subtype was associated with BMD, i.e. osteoporosis risk.